Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svetlana B Panina

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|June 2, 2020
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan CytotoxicityJingqi Pei, Svetlana B Panina, Natalia V Kirienko
Cancer & Metabolism|April 22, 2021
Mitochondrial metabolism as a target for acute myeloid leukemia treatmentSvetlana B Panina, Jingqi Pei, Natalia V Kirienko
RSC Chemical Biology|January 31, 2025
RPRD1B's direct interaction with phosphorylated RNA polymerase II regulates polyadenylation of cell cycle genes and drives cancer progressionRosamaria Y Moreno, Svetlana B Panina, Y Jessie Zhang
Frontiers in Oncology|April 23, 2020
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia TherapySvetlana B Panina, Jingqi Pei, Natalia Baran, et al.
Cell Death & Disease|August 15, 2019
A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugsSvetlana B Panina, Natalia Baran, Fabio H Brasil da Costa, et al.
Nature Communications|September 12, 2024
Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcriptionQian Zhang, Wantae Kim, Svetlana B Panina, et al.
BMC Biology|April 12, 2024
Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cellsSvetlana B Panina, Joshua V Schweer, Qian Zhang, et al.
Science Advances|September 6, 2024
Thr<sup>4</sup> phosphorylation on RNA Pol II occurs at early transcription regulating 3'-end processingRosamaria Y Moreno, Svetlana B Panina, Seema Irani, et al.
Leukemia|June 7, 2022
Novel mitochondria-targeting compounds selectively kill human leukemia cellsSvetlana B Panina, Jingqi Pei, Natalia Baran, et al.
The Protein Journal|November 13, 2017
A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer PatientsOleg I Kit, Dmitry I Vodolazhsky, Denis S Kutilin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|June 2, 2020
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan CytotoxicityJingqi Pei, Svetlana B Panina, Natalia V Kirienko
Cancer & Metabolism|April 22, 2021
Mitochondrial metabolism as a target for acute myeloid leukemia treatmentSvetlana B Panina, Jingqi Pei, Natalia V Kirienko
RSC Chemical Biology|January 31, 2025
RPRD1B's direct interaction with phosphorylated RNA polymerase II regulates polyadenylation of cell cycle genes and drives cancer progressionRosamaria Y Moreno, Svetlana B Panina, Y Jessie Zhang
Frontiers in Oncology|April 23, 2020
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia TherapySvetlana B Panina, Jingqi Pei, Natalia Baran, et al.
Cell Death & Disease|August 15, 2019
A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugsSvetlana B Panina, Natalia Baran, Fabio H Brasil da Costa, et al.
Nature Communications|September 12, 2024
Variation of C-terminal domain governs RNA polymerase II genomic locations and alternative splicing in eukaryotic transcriptionQian Zhang, Wantae Kim, Svetlana B Panina, et al.
BMC Biology|April 12, 2024
Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cellsSvetlana B Panina, Joshua V Schweer, Qian Zhang, et al.
Science Advances|September 6, 2024
Thr<sup>4</sup> phosphorylation on RNA Pol II occurs at early transcription regulating 3'-end processingRosamaria Y Moreno, Svetlana B Panina, Seema Irani, et al.
Leukemia|June 7, 2022
Novel mitochondria-targeting compounds selectively kill human leukemia cellsSvetlana B Panina, Jingqi Pei, Natalia Baran, et al.
The Protein Journal|November 13, 2017
A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer PatientsOleg I Kit, Dmitry I Vodolazhsky, Denis S Kutilin, et al.
Pageof 2